Linezolid - Mild to moderate skin and soft tissue infections
You are here : Home > Formulary Search > Linezolid - Mild to moderate skin and soft tissue infections
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Oral suspension
- Tablets
Formulary Status :
Restrictions / Comments :
Important
Committee were asked to consider the issues associated with the prescribing of linezolid in primary care for mild to moderate skin/soft tissue infections (SSTIs) in patients: Linezolid prescribing for mild to moderate SSTI in line with HPA recommendations is an option for primary care prescribing especially where referral/admission to secondary care is to be avoided. Primary/secondary care interface: Treatment courses that are initiated in secondary care should be supplied by the Trust in their entirety. GPs should not be asked to prescribe the remainder of linezolid courses. Shared care is therefore not considered appropriate for this drug.
Documentation
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Linezolid
Indication :
Mild to moderate skin and soft tissue infections
Group Name :
Keywords :
antibiotic, antibacterial
Brand Names Include :
Zyvox
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Linezolid is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Mild to moderate skin and soft tissue infections.
- No records returned.
Committee Recommendations (1)
22 Feb 12 -
Surrey Medicines Commissioners Group
Committee were asked to consider the issues associated with the prescribing of linezolid in primary care for mild to moderate skin/soft tissue infections (SSTIs) in patients: Linezolid prescribing for mild to moderate SSTI in line with HPA recommendations is an option for primary care prescribing especially where referral/admission to secondary care is to be avoided. Primary/secondary care interface: Treatment courses that are initiated in secondary care should be supplied by the Trust in their entirety. GPs should not be asked to prescribe the remainder of linezolid courses. Shared care is therefore not considered appropriate for this drug. Information sheet [linezolid]to support GPs to be developed.